Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort

Autor: Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, Guillaume Grisay, Riwan Brillet, Célia Dupain, Maud Kamal, Isabelle Guillou, Nadège Gruel, Nicolas Servant, Pierre Gestraud, Jennifer Wong, Vincent Cockenpot, Andreia Goncalves, Janick Selves, Hélène Blons, Etienne Rouleau, Olivier Delattre, Claire Gervais, Christophe Le Tourneau, Ivan Bièche, Yves Allory, Laurence Albigès, Sarah Watson

Publikováno v: npj Precision Oncology, Vol 8, Iss 1, Pp 1-6 (2024)

Abstract Metastatic carcinoma of presumed renal origin (rCUP) has recently emerged as a new entity within the heterogeneous entity of Cancers of Unknown Primary (CUP) but their biological features and optimal therapeutic management remain unknown. We

Externí odkaz: https://doaj.org/article/8884285fa1394307af735d86552e3c29

A regionally based precision medicine implementation initiative in North Africa:The PerMediNA consortium

Autor: Yosr Hamdi, Maroua Boujemaa, Jihenne Ben Aissa-Haj, Fouzia Radouani, Meriem Khyatti, Najah Mighri, Mariem Hannachi, Kais Ghedira, Oussema Souiai, Chaima Hkimi, Mohamed Selim Kammoun, Nesrine Mejri, Hanen Bouaziz, Mohamed Amine Beloufa, Hicham Charoute, Abdelhamid Barakat, Imène Najjar, Hiroaki Taniguchi, Natalia Pietrosemoli, Koussay Dellagi, Sonia Abdelhak, Mohamed Samir Boubaker, Claudia Chica, Etienne Rouleau, Abdellatif benider, Adil El-hamouchi, AIT YOUNES Sonia, Alia Ben Kahla, AMIMER Abdelmalik, AMIR Zine, charif, Amira Jaballah, Amira Louiza, Amina GIHBID, BACHIR Achouak, BELABDI Djihad, BELHADEF Said, BELNOUI Rafika, Belarbi Ayed, Benchakroune Nadia, Benchakroun Nadia, BENINAL Meriem, BENKALI Radja, BENSIHAMDI Asma, BENYOUCEF Hichem, BENDIMRED Thouraya, Bensouf Nadir, BENNOUI Rafika, Berrazegua Yosra, Biskri Latefa, BOUAOUNI Saida, BOUANIKA Meriem, Bouamra Abderezzak, Bouaziz Hanen, Boudinar Fatma Zohra, Bouhara Sabrina, Boussouf Nadir, Boutayeb Saber, BOUNEDJAR Adda, Chabati Omar, Charfeddine Cherine, Chilla Dalia, Chiraz Mehemmai, Cyrine Bouabid, Dahnane Souad, DIAB Soraya, Dib Hocine Adlane, Dorra Wider, DERRAR Fawzi, ELKEBOUB Amina, EL ATTAR Hicham, EL FAHIME Elmostafa, ELHADEF Djazia, Emna Fehri, Farid Hakkou, Farida Hadjam, Fanny Mamboisse, GAIS Widad, GHARNAOUT Merzak, Guessoum Amir Nidhal, HADJAM Farida, HADJ SAHRAOUI, Haifa Rachdi, Hamza Yaiche, HANNACHI Leila, Hassan Mahfouf, Hend Bouguerra, Hicham El Attar, Hichem Ben Hassine, Houda Filali, Houda Harmak, Houda Kanaane, Ichrak Benamri, Imane El Alami, KASSA Reda, Karima Bendahhou, Khaoula Errafii, Khalid El Bairi, Khaali Wafaa, KARKOURI Mehdi, Kabbage Maria, Kammoun Wafa, Kanaane Houda, Kassa Reda, LAOUAR Narimane, Latefa Biskri, Louiza Amira, Louise Marie, Charion Chevalier, MALOUM Nabila, Marc Monot, Mariem Saadi, Mario Campone, Mehdi Mrad, MEHDI KARKOURI, MELIZI Mohamed, Meriem Saadi, Meriem CHAHER, Monia Ardhaoui, Mourad TALEB, Nadia Ben Jmiaa, Nadia Benchakroun, Najet Hadhri, Nawel SALHI, Nezha Taoufiq, Nouha Jandoubi, OUAHIOUNE Wahiba, OULDSLIMANE Salima, Rafika BELNOUI, Rahman Amira Louiza, Rym Benkhalifa, Saber Boutaib, Saber Boutayeb, Samia Menif, Salima OULDSLIMANE, Samuel Valcke, SLIMANI Assia, Sonia Ben Nasr, Sonia Maatoug, Sonia Ait Younes, Souad BENCHEHIDA, Souad BEKOUACI, Souha Sahraoui, Tali Maamar Hassiba, Talha Soraya, TALEB Mourad, TERKMANI Fella, TALHA Soraya, TOUISI Wassila, Wafa Kammoun, Wahiba OUAHIOUNE, Yosra Berrazegua, ZEMMOUR Amel, ZEROUAL Sarah, Zine Charif AMIR, Zineb Zouafi

Publikováno v: Translational Oncology, Vol 44, Iss , Pp 101940- (2024)

Precision Medicine is being increasingly used in the developed world to improve health care. While several Precision Medicine (PM) initiatives have been launched worldwide, their implementations have proven to be more challenging particularly in low-

Externí odkaz: https://doaj.org/article/a76edd34ed914c7887c2118049e17ad9

Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study

Autor: Arnaud Bayle, Laila Belcaid, Lola-Jade Palmieri, Diego Teysonneau, Sophie Cousin, Mariella Spalato-Ceruso, Mihaela Aldea, Damien Vasseur, Melissa Alame, Laura Blouin, Isabelle Soubeyran, Claudio Nicotra, Maud Ngocamus, Antoine Hollebecque, Yohann Loriot, Benjamin Besse, Ludovic Lacroix, Etienne Rouleau, Fabrice Barlesi, Fabrice Andre, Antoine Italiano

Publikováno v: Molecular Cancer, Vol 22, Iss 1, Pp 1-7 (2023)

Abstract Background Despite the effectiveness of the various targeted therapies currently approved for solid tumors, acquired resistance remains a persistent problem that limits the ultimate effectiveness of these treatments. Polyclonal resistance to

Externí odkaz: https://doaj.org/article/52cbb438c71741d8bfa5d463aa3de784

Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients

Autor: Maria Kfoury, Reda El Hazzaz, Claire Sanson, Felix Blanc Durand, Judith Michels, Emeline Colomba Blameble, Roseline Tang, Audrey Le Formal, Elodie Lecerf, Sebastien Gouy, Amandine Maulard, Patricia Pautier, Etienne Rouleau, Alexandra Leary

Publikováno v: Biomarker Research, Vol 11, Iss 1, Pp 1-4 (2023)

Abstract Genomic testing is crucial for the management of ovarian cancer. DNA from biopsies at diagnostic laparoscopies or interval debulking surgery after neoadjuvant chemotherapy, has a high failure rate. At relapse, biopsies may not be feasible. T

Externí odkaz: https://doaj.org/article/0723fed9251a4a12938d6a742423f645

Molecular pathology testing for non-small cell lung cancer: an observational study of elements currently present in request forms and result reports and the opinion of different stakeholders

Autor: Kelly Dufraing, Kaat Van Casteren, Joke Breyne, Nicky D’Haene, Claude Van Campenhout, Sara Vander Borght, Karen Zwaenepoel, Etienne Rouleau, Ed Schuuring, Jan von der Thüsen, Elisabeth Dequeker

Publikováno v: BMC Cancer, Vol 22, Iss 1, Pp 1-20 (2022)

Abstract Background For patients with non-small cell lung cancer (NSCLC), targeted therapies are becoming part of the standard treatment. It is of question which information the clinicians provide on test requests and how the laboratories adapt test

Externí odkaz: https://doaj.org/article/005a0612409243a0b303ce9ae8fd9332